Original news and analysis on international IP policy
Monopoly prices of diagnostic tools and lack of competition in the market constitute a barrier to treatment for people with hepatitis C virus (HCV), but the increased use of “open” diagnostic platforms could reduce prices, a health advocacy research study has found.
Generics industry group Medicines for Europe has declared United States interference in the European Union legislative process on the supplementary protection certificate (SPC) manufacturing waiver “unacceptable,” and an attempt to “influence the outcome of this EU legislative proposal.”
A hundred years ago, the influenza pandemic known as the “Spanish flu” infected one-third of the world population, and resulted in an estimated 50 million deaths. Last week, the World Health Organization held a consultation on possible changes to its 2011 agreement to prepare for the next pandemic influenza. Two major questions were on the table: whether to extend its agreement to seasonal influenza, and how to deal with pandemic influenza genetic information, which is increasingly used instead of biological samples of viruses.
The Group of 77 developing countries plus China delivered a statement at the recent United Nations High-Level Meeting on Tuberculosis, calling for forward progress on the commitments to funding and action made in the UN political declaration on TB.
The Patient Right to Know Drug Prices Act became effective in the United States on 10 October. Among other things, it extends to biologic and biosimilar products a 2003 law requiring drug manufacturers to notify US antitrust authorities of patent settlement agreements. The idea is to cut down on so-called “pay-for delay” tactics which can slow the introduction of cheaper medicines into the market.
The tricontinental research group “accessibsa” has found that while the Indian Patent Office rejects 40 percent of pharmaceutical patent applications, it should be rejecting 90 percent of applications to comply with Indian patent law, according to the results of its recent study of Indian patent data.
The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors.
BERLIN -- Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all.
A new report, “The People's Prescription: Re-imagining health innovation to deliver public value,” calls for restructuring research and development innovation systems to create, rather than extract, value. It also calls for long-term “mission-oriented” public investment, and a public return on this investment.
World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today hailed a dispute settlement decision at the neighbouring World Trade Organization upholding laws requiring tobacco products to be packaged without logos or designs as a way to reduce interest in smoking. Meanwhile, lobbyists for popular alternative "electronic" tobacco products such as vaping are out in force in Geneva this week.
NEW YORK -- The United Nations General Assembly yesterday adopted a high-level political declaration on noncommunicable diseases like cancer and unhealthy lifestyle. And while it gives an infusion of political energy to the issue, some are concerned it did not go far enough and are urging strong actions to follow.
NEW YORK -- The United Nations General Assembly is meeting today for the Third High-Level Meeting on Noncommunicable Diseases, and has adopted an ambitious political declaration, entitled, “Time to Deliver: Accelerating our response to address NCDs for the health and well-being of present and future generations.”